Barclays’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.65M | Buy |
89,434
+15,731
| +21% | +$465K | ﹤0.01% | 2042 |
|
|
2025
Q1 | $2.2M | Sell |
73,703
-6,051
| -8% | -$181K | ﹤0.01% | 1970 |
|
|
2024
Q4 | $2.29M | Buy |
79,754
+4,702
| +6% | +$135K | ﹤0.01% | 2110 |
|
|
2024
Q3 | $2.9M | Buy |
75,052
+45,291
| +152% | +$1.75M | ﹤0.01% | 1910 |
|
|
2024
Q2 | $958K | Sell |
29,761
-17,403
| -37% | -$560K | ﹤0.01% | 2136 |
|
|
2024
Q1 | $1.83M | Sell |
47,164
-25,568
| -35% | -$993K | ﹤0.01% | 2000 |
|
|
2023
Q4 | $2.24M | Buy |
72,732
+33,139
| +84% | +$1.02M | ﹤0.01% | 2079 |
|
|
2023
Q3 | $886K | Buy |
39,593
+5,713
| +17% | +$128K | ﹤0.01% | 2172 |
|
|
2023
Q2 | $728K | Sell |
33,880
-769
| -2% | -$16.5K | ﹤0.01% | 2369 |
|
|
2023
Q1 | $831K | Buy |
34,649
+4,427
| +15% | +$106K | ﹤0.01% | 2268 |
|
|
2022
Q4 | $701K | Buy |
30,222
+3,886
| +15% | +$90.1K | ﹤0.01% | 2370 |
|
|
2022
Q3 | $423K | Sell |
26,336
-15,007
| -36% | -$241K | ﹤0.01% | 2685 |
|
|
2022
Q2 | $732K | Sell |
41,343
-7,683
| -16% | -$136K | ﹤0.01% | 2294 |
|
|
2022
Q1 | $998K | Sell |
49,026
-23,565
| -32% | -$480K | ﹤0.01% | 2306 |
|
|
2021
Q4 | $1.36M | Sell |
72,591
-11,569
| -14% | -$216K | ﹤0.01% | 2022 |
|
|
2021
Q3 | $1.66M | Buy |
84,160
+33,747
| +67% | +$666K | ﹤0.01% | 1981 |
|
|
2021
Q2 | $1.19M | Sell |
50,413
-23,229
| -32% | -$549K | ﹤0.01% | 2015 |
|
|
2021
Q1 | $1.75M | Buy |
73,642
+62,394
| +555% | +$1.48M | ﹤0.01% | 1966 |
|
|
2020
Q4 | $225K | Sell |
11,248
-4,547
| -29% | -$91K | ﹤0.01% | 2654 |
|
|
2020
Q3 | $328K | Sell |
15,795
-3,137
| -17% | -$65.1K | ﹤0.01% | 2506 |
|
|
2020
Q2 | $331K | Buy |
18,932
+8,055
| +74% | +$141K | ﹤0.01% | 2543 |
|
|
2020
Q1 | $178K | Sell |
10,877
-21,284
| -66% | -$348K | ﹤0.01% | 2597 |
|
|
2019
Q4 | $662K | Buy |
32,161
+7,753
| +32% | +$160K | ﹤0.01% | 2536 |
|
|
2019
Q3 | $280K | Buy |
24,408
+2,108
| +9% | +$24.2K | ﹤0.01% | 2908 |
|
|
2019
Q2 | $293K | Sell |
22,300
-29,557
| -57% | -$388K | ﹤0.01% | 2994 |
|
|
2019
Q1 | $786K | Buy |
51,857
+14,150
| +38% | +$214K | ﹤0.01% | 2323 |
|
|
2018
Q4 | $648K | Buy |
37,707
+26,688
| +242% | +$459K | ﹤0.01% | 2107 |
|
|
2018
Q3 | $162K | Buy |
11,019
+4,709
| +75% | +$69.2K | ﹤0.01% | 3177 |
|
|
2018
Q2 | $150K | Sell |
6,310
-4,447
| -41% | -$106K | ﹤0.01% | 2894 |
|
|
2018
Q1 | $276K | Buy |
10,757
+5,713
| +113% | +$147K | ﹤0.01% | 2654 |
|
|
2017
Q4 | $93K | Buy |
5,044
+4,518
| +859% | +$83.3K | ﹤0.01% | 3039 |
|
|
2017
Q3 | $6K | Buy |
526
+291
| +124% | +$3.32K | ﹤0.01% | 3580 |
|
|
2017
Q2 | $3K | Sell |
235
-5,856
| -96% | -$74.8K | ﹤0.01% | 3613 |
|
|
2017
Q1 | $62K | Sell |
6,091
-10,516
| -63% | -$107K | ﹤0.01% | 3021 |
|
|
2016
Q4 | $258K | Buy |
16,607
+5,299
| +47% | +$82.3K | ﹤0.01% | 2177 |
|
|
2016
Q3 | $218K | Buy |
11,308
+10,994
| +3,501% | +$212K | ﹤0.01% | 2099 |
|
|
2016
Q2 | $4K | Buy |
314
+200
| +175% | +$2.55K | ﹤0.01% | 3147 |
|
|
2016
Q1 | $2K | Sell |
114
-210
| -65% | -$3.68K | ﹤0.01% | 3201 |
|
|
2015
Q4 | $9K | Buy |
324
+289
| +826% | +$8.03K | ﹤0.01% | 2831 |
|
|
2015
Q3 | $1K | Sell |
35
-93
| -73% | -$2.66K | ﹤0.01% | 3672 |
|
|
2015
Q2 | $2K | Buy |
+128
| New | +$2K | ﹤0.01% | 3896 |
|